Loading…

Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines

A method for increasing vaccine access and coverage, especially among hard-to-reach populations, CTC permits certain vaccines used in single antigen delivery strategies or campaign scenarios to be kept outside of the traditional cold chain of +2°C to +8°C for a short period of time under monitored a...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2017-04, Vol.35 (17), p.2214-2216
Main Authors: Kahn, Anna-Lea, Kristensen, Debra, Rao, Raja
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c495t-692289717dd820f872f37c78d31952fedf0cb8e1b5ac80695e6146667fac9ee33
cites cdi_FETCH-LOGICAL-c495t-692289717dd820f872f37c78d31952fedf0cb8e1b5ac80695e6146667fac9ee33
container_end_page 2216
container_issue 17
container_start_page 2214
container_title Vaccine
container_volume 35
creator Kahn, Anna-Lea
Kristensen, Debra
Rao, Raja
description A method for increasing vaccine access and coverage, especially among hard-to-reach populations, CTC permits certain vaccines used in single antigen delivery strategies or campaign scenarios to be kept outside of the traditional cold chain of +2°C to +8°C for a short period of time under monitored and controlled conditions that are appropriate to the stability of the antigen. The CTC approach also uses two specific and complementary temperature monitoring tools: (1) a peak threshold temperature indicator which allows for brief- though all the same harmful- exposures to high temperatures to be detected and (2) the VVM which measures accumulated heat exposures during unintentional cold chain excursions and is limited to a calibration for an upper temperature limit of +37°C. CTC therefore not only formally allows for cold chain excursions through the regulatory approval process, but also extends their flexibility and improves the associated temperature monitoring. A growing and compelling body of evidence shows CTC offers valuable opportunities for maximizing supply chain efficiencies, safeguarding cold chain investments, and protecting more children and families from vaccine-preventable diseases. Lack of transportation infrastructure, such as navigable roads and sufficiently large vehicles, requiring vaccines to be transported in smaller vaccine carriers and often over arduous terrain by motorcycle, bicycle, or boat, when available, or on foot [3]; Lengthy and burdensome preparation of conditioned ice packs to keep vaccines sufficiently cold while also avoiding freezing, which occupies staff time and diverts attention away from routine activities; Constraints on time, staff, and equipment that result from maintaining...
doi_str_mv 10.1016/j.vaccine.2016.10.091
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1883843389</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0264410X16312075</els_id><sourcerecordid>1883843389</sourcerecordid><originalsourceid>FETCH-LOGICAL-c495t-692289717dd820f872f37c78d31952fedf0cb8e1b5ac80695e6146667fac9ee33</originalsourceid><addsrcrecordid>eNqFkk2P0zAQhi0EYsvCTwBF4sIlxR-JPy4gtFo-pJU4ABI3y7UnrUtiZ-2kovDncWgBaS-cLM88M57X7yD0lOA1wYS_3K8PxlofYE3LtcTWWJF7aEWkYDVtibyPVpjypm4I_nqBHuW8xxi3jKiH6IJKxhvFmhX6ef19guB82FZ5Hsf-WNmd8SFXJrjKD2OKhyXnh2EO_oeZfAyVjQdIZgu_Gbid_XSspl2K83ZXcmFKse_BVRMMY-GmOcGpaTVnqGJXnQfPj9GDzvQZnpzPS_Tl7fXnq_f1zcd3H67e3NS2Ue1Uc0WpVIII5yTFnRS0Y8IK6YqWlnbgOmw3EsimNVZirlrgpOGci85YBcDYJXpx6lvU3M6QJz34bKHvTYA4Z02kZLJhTKqCPr-D7uOcQpluoYQSXEhaqPZE2RRzTtDpMfnBpKMmWC_u6L0-i9SLO0u4uFPqnp27z5sB3N-qP3YU4PUJgPIdBw9JZ-shWHA-gZ20i_6_T7y608H2Pnhr-m9whPxPjc5UY_1pWZFlQwhnhGLRsl-gp7pV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1887976782</pqid></control><display><type>article</type><title>Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Kahn, Anna-Lea ; Kristensen, Debra ; Rao, Raja</creator><creatorcontrib>Kahn, Anna-Lea ; Kristensen, Debra ; Rao, Raja</creatorcontrib><description>A method for increasing vaccine access and coverage, especially among hard-to-reach populations, CTC permits certain vaccines used in single antigen delivery strategies or campaign scenarios to be kept outside of the traditional cold chain of +2°C to +8°C for a short period of time under monitored and controlled conditions that are appropriate to the stability of the antigen. The CTC approach also uses two specific and complementary temperature monitoring tools: (1) a peak threshold temperature indicator which allows for brief- though all the same harmful- exposures to high temperatures to be detected and (2) the VVM which measures accumulated heat exposures during unintentional cold chain excursions and is limited to a calibration for an upper temperature limit of +37°C. CTC therefore not only formally allows for cold chain excursions through the regulatory approval process, but also extends their flexibility and improves the associated temperature monitoring. A growing and compelling body of evidence shows CTC offers valuable opportunities for maximizing supply chain efficiencies, safeguarding cold chain investments, and protecting more children and families from vaccine-preventable diseases. Lack of transportation infrastructure, such as navigable roads and sufficiently large vehicles, requiring vaccines to be transported in smaller vaccine carriers and often over arduous terrain by motorcycle, bicycle, or boat, when available, or on foot [3]; Lengthy and burdensome preparation of conditioned ice packs to keep vaccines sufficiently cold while also avoiding freezing, which occupies staff time and diverts attention away from routine activities; Constraints on time, staff, and equipment that result from maintaining...</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/j.vaccine.2016.10.091</identifier><identifier>PMID: 28364934</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Access control ; Allergy and Immunology ; Bicycles ; Body temperature ; Brittleness ; Children ; Cold ; Cold chain ; Conditioning ; Control stability ; Controlled conditions ; Controlled temperature chain ; Drug delivery systems ; Drug Storage - economics ; Drug Storage - methods ; Exposure ; Feet ; Freezing ; High temperature ; Humans ; Immunization ; Immunization Programs - methods ; Immunization Programs - trends ; Monitoring ; Refrigeration - instrumentation ; Refrigeration - methods ; Supply chain ; Supply chains ; Temperature ; Temperature effects ; Terrain ; Tonic immobility ; Transportation engineering ; Vaccination Coverage ; Vaccine ; Vaccines ; Vaccines - supply &amp; distribution</subject><ispartof>Vaccine, 2017-04, Vol.35 (17), p.2214-2216</ispartof><rights>The Authors</rights><rights>2017 The Authors</rights><rights>Copyright Elsevier Limited Apr 19, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c495t-692289717dd820f872f37c78d31952fedf0cb8e1b5ac80695e6146667fac9ee33</citedby><cites>FETCH-LOGICAL-c495t-692289717dd820f872f37c78d31952fedf0cb8e1b5ac80695e6146667fac9ee33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28364934$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kahn, Anna-Lea</creatorcontrib><creatorcontrib>Kristensen, Debra</creatorcontrib><creatorcontrib>Rao, Raja</creatorcontrib><title>Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>A method for increasing vaccine access and coverage, especially among hard-to-reach populations, CTC permits certain vaccines used in single antigen delivery strategies or campaign scenarios to be kept outside of the traditional cold chain of +2°C to +8°C for a short period of time under monitored and controlled conditions that are appropriate to the stability of the antigen. The CTC approach also uses two specific and complementary temperature monitoring tools: (1) a peak threshold temperature indicator which allows for brief- though all the same harmful- exposures to high temperatures to be detected and (2) the VVM which measures accumulated heat exposures during unintentional cold chain excursions and is limited to a calibration for an upper temperature limit of +37°C. CTC therefore not only formally allows for cold chain excursions through the regulatory approval process, but also extends their flexibility and improves the associated temperature monitoring. A growing and compelling body of evidence shows CTC offers valuable opportunities for maximizing supply chain efficiencies, safeguarding cold chain investments, and protecting more children and families from vaccine-preventable diseases. Lack of transportation infrastructure, such as navigable roads and sufficiently large vehicles, requiring vaccines to be transported in smaller vaccine carriers and often over arduous terrain by motorcycle, bicycle, or boat, when available, or on foot [3]; Lengthy and burdensome preparation of conditioned ice packs to keep vaccines sufficiently cold while also avoiding freezing, which occupies staff time and diverts attention away from routine activities; Constraints on time, staff, and equipment that result from maintaining...</description><subject>Access control</subject><subject>Allergy and Immunology</subject><subject>Bicycles</subject><subject>Body temperature</subject><subject>Brittleness</subject><subject>Children</subject><subject>Cold</subject><subject>Cold chain</subject><subject>Conditioning</subject><subject>Control stability</subject><subject>Controlled conditions</subject><subject>Controlled temperature chain</subject><subject>Drug delivery systems</subject><subject>Drug Storage - economics</subject><subject>Drug Storage - methods</subject><subject>Exposure</subject><subject>Feet</subject><subject>Freezing</subject><subject>High temperature</subject><subject>Humans</subject><subject>Immunization</subject><subject>Immunization Programs - methods</subject><subject>Immunization Programs - trends</subject><subject>Monitoring</subject><subject>Refrigeration - instrumentation</subject><subject>Refrigeration - methods</subject><subject>Supply chain</subject><subject>Supply chains</subject><subject>Temperature</subject><subject>Temperature effects</subject><subject>Terrain</subject><subject>Tonic immobility</subject><subject>Transportation engineering</subject><subject>Vaccination Coverage</subject><subject>Vaccine</subject><subject>Vaccines</subject><subject>Vaccines - supply &amp; distribution</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqFkk2P0zAQhi0EYsvCTwBF4sIlxR-JPy4gtFo-pJU4ABI3y7UnrUtiZ-2kovDncWgBaS-cLM88M57X7yD0lOA1wYS_3K8PxlofYE3LtcTWWJF7aEWkYDVtibyPVpjypm4I_nqBHuW8xxi3jKiH6IJKxhvFmhX6ef19guB82FZ5Hsf-WNmd8SFXJrjKD2OKhyXnh2EO_oeZfAyVjQdIZgu_Gbid_XSspl2K83ZXcmFKse_BVRMMY-GmOcGpaTVnqGJXnQfPj9GDzvQZnpzPS_Tl7fXnq_f1zcd3H67e3NS2Ue1Uc0WpVIII5yTFnRS0Y8IK6YqWlnbgOmw3EsimNVZirlrgpOGci85YBcDYJXpx6lvU3M6QJz34bKHvTYA4Z02kZLJhTKqCPr-D7uOcQpluoYQSXEhaqPZE2RRzTtDpMfnBpKMmWC_u6L0-i9SLO0u4uFPqnp27z5sB3N-qP3YU4PUJgPIdBw9JZ-shWHA-gZ20i_6_T7y608H2Pnhr-m9whPxPjc5UY_1pWZFlQwhnhGLRsl-gp7pV</recordid><startdate>20170419</startdate><enddate>20170419</enddate><creator>Kahn, Anna-Lea</creator><creator>Kristensen, Debra</creator><creator>Rao, Raja</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T2</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20170419</creationdate><title>Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines</title><author>Kahn, Anna-Lea ; Kristensen, Debra ; Rao, Raja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c495t-692289717dd820f872f37c78d31952fedf0cb8e1b5ac80695e6146667fac9ee33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Access control</topic><topic>Allergy and Immunology</topic><topic>Bicycles</topic><topic>Body temperature</topic><topic>Brittleness</topic><topic>Children</topic><topic>Cold</topic><topic>Cold chain</topic><topic>Conditioning</topic><topic>Control stability</topic><topic>Controlled conditions</topic><topic>Controlled temperature chain</topic><topic>Drug delivery systems</topic><topic>Drug Storage - economics</topic><topic>Drug Storage - methods</topic><topic>Exposure</topic><topic>Feet</topic><topic>Freezing</topic><topic>High temperature</topic><topic>Humans</topic><topic>Immunization</topic><topic>Immunization Programs - methods</topic><topic>Immunization Programs - trends</topic><topic>Monitoring</topic><topic>Refrigeration - instrumentation</topic><topic>Refrigeration - methods</topic><topic>Supply chain</topic><topic>Supply chains</topic><topic>Temperature</topic><topic>Temperature effects</topic><topic>Terrain</topic><topic>Tonic immobility</topic><topic>Transportation engineering</topic><topic>Vaccination Coverage</topic><topic>Vaccine</topic><topic>Vaccines</topic><topic>Vaccines - supply &amp; distribution</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kahn, Anna-Lea</creatorcontrib><creatorcontrib>Kristensen, Debra</creatorcontrib><creatorcontrib>Rao, Raja</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Family Health Database (Proquest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kahn, Anna-Lea</au><au>Kristensen, Debra</au><au>Rao, Raja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>2017-04-19</date><risdate>2017</risdate><volume>35</volume><issue>17</issue><spage>2214</spage><epage>2216</epage><pages>2214-2216</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>A method for increasing vaccine access and coverage, especially among hard-to-reach populations, CTC permits certain vaccines used in single antigen delivery strategies or campaign scenarios to be kept outside of the traditional cold chain of +2°C to +8°C for a short period of time under monitored and controlled conditions that are appropriate to the stability of the antigen. The CTC approach also uses two specific and complementary temperature monitoring tools: (1) a peak threshold temperature indicator which allows for brief- though all the same harmful- exposures to high temperatures to be detected and (2) the VVM which measures accumulated heat exposures during unintentional cold chain excursions and is limited to a calibration for an upper temperature limit of +37°C. CTC therefore not only formally allows for cold chain excursions through the regulatory approval process, but also extends their flexibility and improves the associated temperature monitoring. A growing and compelling body of evidence shows CTC offers valuable opportunities for maximizing supply chain efficiencies, safeguarding cold chain investments, and protecting more children and families from vaccine-preventable diseases. Lack of transportation infrastructure, such as navigable roads and sufficiently large vehicles, requiring vaccines to be transported in smaller vaccine carriers and often over arduous terrain by motorcycle, bicycle, or boat, when available, or on foot [3]; Lengthy and burdensome preparation of conditioned ice packs to keep vaccines sufficiently cold while also avoiding freezing, which occupies staff time and diverts attention away from routine activities; Constraints on time, staff, and equipment that result from maintaining...</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>28364934</pmid><doi>10.1016/j.vaccine.2016.10.091</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0264-410X
ispartof Vaccine, 2017-04, Vol.35 (17), p.2214-2216
issn 0264-410X
1873-2518
language eng
recordid cdi_proquest_miscellaneous_1883843389
source ScienceDirect Freedom Collection 2022-2024
subjects Access control
Allergy and Immunology
Bicycles
Body temperature
Brittleness
Children
Cold
Cold chain
Conditioning
Control stability
Controlled conditions
Controlled temperature chain
Drug delivery systems
Drug Storage - economics
Drug Storage - methods
Exposure
Feet
Freezing
High temperature
Humans
Immunization
Immunization Programs - methods
Immunization Programs - trends
Monitoring
Refrigeration - instrumentation
Refrigeration - methods
Supply chain
Supply chains
Temperature
Temperature effects
Terrain
Tonic immobility
Transportation engineering
Vaccination Coverage
Vaccine
Vaccines
Vaccines - supply & distribution
title Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T14%3A10%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extending%20supply%20chains%20and%20improving%20immunization%20coverage%20and%20equity%20through%20controlled%20temperature%20chain%20use%20of%20vaccines&rft.jtitle=Vaccine&rft.au=Kahn,%20Anna-Lea&rft.date=2017-04-19&rft.volume=35&rft.issue=17&rft.spage=2214&rft.epage=2216&rft.pages=2214-2216&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/j.vaccine.2016.10.091&rft_dat=%3Cproquest_cross%3E1883843389%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c495t-692289717dd820f872f37c78d31952fedf0cb8e1b5ac80695e6146667fac9ee33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1887976782&rft_id=info:pmid/28364934&rfr_iscdi=true